journal article·2021-01Open access

Synthesis of novel polymeric nanoparticles (methoxy-polyethylene glycol-chitosan/hyaluronic acid) containing 7-ethyl-10-hydroxycamptothecin for colon cancer therapy: in vitro, ex vivo and in vivo investigation

Faezeh Sharifi, Mansour Jahangiri, Pedram Ebrahimnejad

Abstract

The goal of the current study was to target 7-ethyl-10-hydroxycamptothecin (SN38) orally to colon tumours by synthesizing a targeting polymer. To achieve the optimum delivery for SN38, initially methoxy-polyethylene glycol (mPEG)-chitosan was synthesized and then nanoparticles were developed through ionic gelation between mPEG-chitosan and hyaluronic acid as a ligand for cell-surface glycoprotein CD44 receptor. The SN38 was loaded in nanoparticles (SN38-NPs) using the non-covalent physical adsorption method. The size of the optimized SN38-NPs was 226.7 nm, encapsulation efficiency was 89.23% and drug content was 7.98 ± 0.54% in the optimum formulation. The attachment of mPEG to chitosan was confirmed by proton nuclear magnetic resonance. The results of differential scanning calorimetry and Fourier transforms infra-red analysis indicated that SN38 existed in amorphous form and functional groups of SN38 protected in the formulations which could be a sign of suitable encapsulation of SN38 in SN38-NPs. In vitro study indicated that SN38-NPs were more potent against the cancer cells than free SN38. The cellular uptake of SN38-NPs improved up to 1.6-fold against human colorectal adenocarcinoma (Caco-2) cells. Moreover, SN38-NPs remarkably demonstrated superior anti-tumor efficacy in contrary to pure SN38. This suggests the advantage of SN38-NPs as a potent oral drug carrier which could be further explored for clinical investigations.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Drug Transport and Resistance Mechanisms · Intraperitoneal and Appendiceal Malignancies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Faculty of Chemical, Petroleum and Gas Engineering, Semnan University, Semnan, I.R. Iran

Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

Pharmaceutical Science Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran

References (52)

Show source-provided references
1. Khalek FJA, Gallicano GI, Mishra L. Colon cancer stem cells. Gastrointest Cancer Res. 2010;(Suppl 1):S16.
2. 10.1016/j.ijpharm.2010.12.02210.1016/j.ijpharm.2010.12.022 ↗
3. Mohammady H, Dinarvand R, Esfandyari MM, et al. Encapsulation of irinotecan in polymeric nanoparticles: characterization, release kinetic and cytotoxicity evaluation. Nanomed J. 2016;3(3):159–168.
4. Ebrahimnejad P, Dinarvand R, Sajadi S, et al. Preparation and characterization of poly lactide-co-glycolide nanoparticles of SN-38. PDA J Pharm Sci Technol. 2009;63(6):512–520.
5. 10.1088/0957-4484/24/24/24510110.1088/0957-4484/24/24/245101 ↗
6. 10.1016/j.nano.2009.10.00310.1016/j.nano.2009.10.003 ↗
7. 10.1016/j.colsurfb.2020.11113510.1016/j.colsurfb.2020.111135 ↗
8. 10.2174/1573413711309999007110.2174/15734137113099990071 ↗
9. 10.1016/j.ijbiomac.2015.03.06610.1016/j.ijbiomac.2015.03.066 ↗
10. 10.1080/09205063.2018.154150010.1080/09205063.2018.1541500 ↗
11. 10.1016/j.biomaterials.2019.11924710.1016/j.biomaterials.2019.119247 ↗
12. 10.1016/j.ejpb.2011.01.02110.1016/j.ejpb.2011.01.021 ↗
13. 10.3109/21691401.2015.110523910.3109/21691401.2015.1105239 ↗
14. 10.1021/acs.molpharmaceut.5b0078510.1021/acs.molpharmaceut.5b00785 ↗
15. Mir M, Ebrahimnejad P. Preparation and characterization of bifunctional nanoparticles of vitamin E TPGS-emulsified PLGA-PEG-FOL containing deferasirox. J Nanosci Nanotechnol. 2015;4(2):80–87.
16. 10.1002/advs.20170107910.1002/advs.201701079 ↗
17. 10.1016/j.jconrel.2013.09.03210.1016/j.jconrel.2013.09.032 ↗
18. 10.18632/oncotarget.999810.18632/oncotarget.9998 ↗
19. 10.1080/02652048.2019.161736010.1080/02652048.2019.1617360 ↗
20. 10.1016/j.mycmed.2020.10101410.1016/j.mycmed.2020.101014 ↗
21. 10.1016/j.ejps.2019.01.03510.1016/j.ejps.2019.01.035 ↗
22. 10.1016/j.ijbiomac.2013.11.02710.1016/j.ijbiomac.2013.11.027 ↗
23. 10.1016/j.carbpol.2019.11500110.1016/j.carbpol.2019.115001 ↗
24. 10.1016/j.carbpol.2019.11500210.1016/j.carbpol.2019.115002 ↗
25. Khalili S, Ebrahimnezhad P. Survival of Lactobacillus Acidophilus as probiotic bacteria using chitosan nanoparticles. Int J Eng. 2017;30(4):456–463.
26. 10.3109/1083745090292273610.3109/10837450902922736 ↗
27. 10.1016/j.biomaterials.2009.01.01710.1016/j.biomaterials.2009.01.017 ↗
28. Jafari M, Heidari D, Ebrahimnejad P. Synthesizing and characterizing functionalized short multiwall carbon nanotubes with folate, magnetite and polyethylene glycol as multi-targeted nanocarrier of anti-cancer drugs. Iran J Pharm Res. 2016;15(2):449–456.
29. 10.2147/IJN.S3961510.2147/IJN.S39615 ↗
30. 10.1016/j.ejpb.2007.08.00910.1016/j.ejpb.2007.08.009 ↗
31. 10.1016/j.nano.2020.10222710.1016/j.nano.2020.102227 ↗
32. 10.1080/21691401.2018.147778910.1080/21691401.2018.1477789 ↗
33. 10.1016/j.msec.2018.12.13810.1016/j.msec.2018.12.138 ↗
34. 10.1002/mabi.20050004810.1002/mabi.200500048 ↗
35. 10.1016/j.ijbiomac.2014.10.03910.1016/j.ijbiomac.2014.10.039 ↗
36. Ebrahimnejad P, Dinarvand R, Sajadi A, et al. Development and validation of an ion-pair HPLC chromatography for simultaneous determination of lactone and carboxylate forms of SN-38 in nanoparticles. J Food Drug Anal. 2009;17(4):246–256.
37. 10.1016/j.molliq.2019.11128510.1016/j.molliq.2019.111285 ↗
38. 10.1016/j.jddst.2020.10157910.1016/j.jddst.2020.101579 ↗
39. Sharifi F, Jahangiri M. Investigation of the stability of vitamin D in emulsion-based delivery systems. Chem Ind Chem Eng. 2018;24(2):28.
40. 10.1016/j.ijbiomac.2013.09.04110.1016/j.ijbiomac.2013.09.041 ↗
41. 10.1016/j.jconrel.2005.12.01510.1016/j.jconrel.2005.12.015 ↗
42. 10.2147/IJN.S19378310.2147/IJN.S193783 ↗
43. 10.1088/0957-4484/23/20/20510110.1088/0957-4484/23/20/205101 ↗
44. 10.1016/j.ijpharm.2015.08.06010.1016/j.ijpharm.2015.08.060 ↗
45. 10.3390/md1212623610.3390/md12126236 ↗
46. Vangara KK, Liu JL, Palakurthi S. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer. Anticancer Res. 2013;33(6):2425–2434.
47. 10.1007/s12272-013-0276-210.1007/s12272-013-0276-2 ↗
48. 10.1016/S1359-6446(04)03354-910.1016/S1359-6446(04)03354-9 ↗
49. 10.1023/A:101593760510010.1023/A:1015937605100 ↗
50. 10.1016/j.biomaterials.2010.11.01010.1016/j.biomaterials.2010.11.010 ↗
51. 10.1016/j.jddst.2020.10196910.1016/j.jddst.2020.101969 ↗
52. 10.1038/nbt.333010.1038/nbt.3330 ↗